Clinical Trials Logo

Pre-diabetes clinical trials

View clinical trials related to Pre-diabetes.

Filter by:

NCT ID: NCT01218061 Active, not recruiting - Pre-diabetes Clinical Trials

Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)

IT-DIAB
Start date: June 2010
Phase: N/A
Study type: Interventional

The main objective of the study is to follow prospectively a cohort of patients with pre-diabetes to understand the pathophysiological mechanisms involved in switching from pre-diabetes to type 2 diabetes and to identify new biomarkers of type 2 diabetes risk in this population.

NCT ID: NCT01107431 Completed - Pre-diabetes Clinical Trials

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

L-Arabinose
Start date: December 2008
Phase: N/A
Study type: Interventional

This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).

NCT ID: NCT01052025 Recruiting - Type 2 Diabetes Clinical Trials

Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance

Start date: August 2009
Phase: Phase 4
Study type: Interventional

The incidence rate of type 2 diabetes in Thai populations is high and increasing every year. Cardiovascular disease is the main complication of this disease, which has been defined as an important cause of death among Diabetic patients. This disease is now becoming a major health problem and causes a great economic loss to the country. Evidence shows that Curcumin, Thai herbal medicine, has the effectiveness of prevention and delay of type 2 diabetes. However, there is no scientific study that aims to prove the efficacy of this herb particularly for prevention and delay the disease in Patients with impaired glucose tolerance (pre-diabetes) and insulin resistance.

NCT ID: NCT01034319 Active, not recruiting - Metabolic Syndrome Clinical Trials

Genetic Counseling and Lifestyle Change for Diabetes Prevention

GC/LC
Start date: December 2009
Phase: Phase 2
Study type: Interventional

This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Controls will not be tested. All subjects will be enrolled in a 12-week diabetes prevention program.

NCT ID: NCT01004848 Completed - Pre-diabetes Clinical Trials

Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

HEED
Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of a peer-led community-based lifestyle intervention, versus usual care, in achieving weight loss and prevention of diabetes among overweight adults with pre-diabetes in East Harlem.

NCT ID: NCT00962962 Completed - Pre-Diabetes Clinical Trials

Exercise Dose-Response Effects in Prediabetes

STRRIDE-PD
Start date: July 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effects of different amounts and intensities of aerobic exercise training programs, with and without weight loss, in people who are at risk for diabetes. An additional purpose of the study is to evaluate the factors in the blood and in exercising muscles that contribute to the improvement in those risk factors. This information will be used to improve exercise training guidelines for improving cardiovascular and metabolic health in people with abnormal fasting glucose, also known as prediabetes.

NCT ID: NCT00879801 Completed - Pre-Diabetes Clinical Trials

Genetic Physiopathology and Evolution of Type 2 Diabetes

GENFIEV
Start date: January 2003
Phase: N/A
Study type: Observational

There are few longitudinal studies in the Caucasian population and even less in the Italian population in subjects with impaired glucose regulation to allow: 1. An estimate of the rate of conversion to type 2 diabetes; 2. To identify subjects at risk; and 3. To assess the physiopathologic mechanisms responsible for the conversion. In order to set up a longitudinal study capable of defining the above parameters it is mandatory that the physiological, biochemical, and, genetic markers specific for IGR are identified. The goals of the present research proposal are: 1. To clarify the physiological mechanisms responsible for IGR; 2. To identify the biochemical and beta-cell auto-immune parameters present in IGR; 3. Identify genetic markers. The subjects who will be identified will add up to other 900 individuals who will be recruited as part of a follow-up program sponsored by the Italian Society of Diabetes, specifically designed to assess conversion rate to diabetes.

NCT ID: NCT00876928 Completed - Pre-diabetes Clinical Trials

Vitamin D in Minorities With Prediabetes

Start date: March 2009
Phase: N/A
Study type: Interventional

Vitamin D supplementation in minority subjects with both pre-diabetes and low vitamin D levels will delay the development of diabetes.

NCT ID: NCT00853801 Completed - Type 2 Diabetes Clinical Trials

Integrating Lifestyle Therapy for Diabetes Prevention Into Primary Care

Start date: February 2006
Phase: N/A
Study type: Interventional

An educational intervention in the General Medicine Clinic aimed at both primary care providers (PCPs) and their patients with metabolic syndrome/pre-diabetes (MetSyn/PDM). Improving PCPs ability to detect and manage MetSyn/PDM, as measured by the increased incorporation of MetSyn/PDM into PCPs care plan, and increasing patients' awareness of healthy lifestyle behaviors results in positive patient health behaviors and outcomes.

NCT ID: NCT00842426 Completed - Obesity Clinical Trials

Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care

E-LITE
Start date: June 2009
Phase: Phase 2
Study type: Interventional

The purpose of the E-LITE Study is to evaluate the feasibility and potential effectiveness of two lifestyle interventions in a community based primary care setting. The study aims to assess how changes in diet, exercise, and behavioral self-management affect weight and related risk factors for adults at risk for diabetes and cardiovascular disease.